Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neostigmine + atropine for prevention of post-dural puncture headache after spinal anesthesia
IRCT20200825048515N11Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Nov 2020
- Modality
- Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of neostigmine and atropine in post-dural puncture headache (PDPH) (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Severity of headache and Duration of headache. Started Nov 2020; status: completed.
02
Drugs
neostigmineatropine
03
Conditions
post-dural puncture headache (PDPH)
Beyond the preview
Go deeper on IRCT20200825048515N11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200825048515N11.